Clinical trial
Study of the Involvement of IL-17 / IL-22 Pathway in Bacterial Exacerbations of COPD
NCT02655302 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the Involvement of IL-17 / IL-22 Pathway in Bacterial Exacerbations of COPD
- Lead sponsor
- University Hospital, Lille
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- July 4, 2018
- Completion date
- September 13, 2023
- Enrollment
- 23 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.